FBM Regimen in HSCT for MDS

Conditions: Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2; Myelodysplastic Syndromes Interventions: Drug: Fludarabine, Busulfan and Melphalan Sponsors: Ruijin Hospital Recruiting

https://clinicaltrials.gov/study/NCT06247917

Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

More News: Hospitals | Myelodysplastic Syndrome | Research